Data visualizations list
All data visualizations contained within the Observatory are listed below, under monitoring, benchmarking or indicators as appropriate. (These visualizations can also be accessed by clicking on Monitoring, Benchmarking or Indicators on the left-hand menu on any page within the Observatory).
Monitoring R&D activities
Inputs to R&D
Health R&D funding flows by disease
Health R&D funding flows by country
4. Gross domestic R&D expenditure on health (health GERD) as a % of total GERD
Grants for health research by major funders
8. Funding landscape for research on health, migration and displacement
Capacity for undertaking health R&D
9. Health researchers (in full-time equivalent), as a proportion of all researchers
Processes for R&D
Pipeline analysis for health products
12. WHO landscape of clinical trials on monoclonal antibodies
13. WHO review of antibacterial agents in clinical development for priority drug-resistant pathogens
15. WHO review of bacterial vaccines in development for priority drug-resistant pathogens
16. WHO review of vector control interventions in the pipeline
17. WHO review of malaria vaccine clinical development
18. WHO review of childhood cancer drug landscape and pipeline characteristics
19. WHO review of childhood cancer chimeric antigen receptor (CAR) T-cell therapy in development
20. WHO review of the regulatory approval status of drugs in paediatric cancer trials
21. WHO landscape of clinical trials on cancer
22. WHO review of the drugs pipeline for neglected tropical diseases
Clinical trials registration
23. Clinical trials registration by year and location (WHO ICTRP)
25. WHO landscape of pediatric clinical trials
Outputs for R&D
Publications arising from health research
26. Trends and volume of peer-reviewed publications for neglected diseases (GoPubMed)
Benchmarking R&D activities
Benchmarking performance across countries
Funding flows for health R&D of all kind
Benchmarking R&D activities against burden of disease
Health R&D investments and publications
Benchmarking R&D activities against research conduct standards
Standards for clinical trials practice
Global R&D indicators
SDG indicator 3.b.2
SDG indicator 9.5.1
33. Gross domestic R&D expenditure on health (health GERD) as a % of gross domestic product (GDP)
SDG indicator 9.5.2
34. Health researchers (in full-time equivalent) per million inhabitants by WHO region
35. Health researchers (in full-time equivalent) per million inhabitants by income group